Evidence map›Paper›PMID 28887505›Full record

ArticleScientific reports2017

Impaired fibrinolysis and lower levels of plasma α

Stanislawa Bazan-Socha, Lucyna Mastalerz, Agnieszka Cybulska, Lech Zareba, Romy Kremers, Michal Zabczyk, Grazyna Pulka, Teresa Iwaniec, Jan G Bazan, Coenraad Hemker and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Asthma and stroke: a narrative review.Asthma research and practice · 2021
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Stanislawa Bazan-SochaDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Lucyna MastalerzDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Agnieszka CybulskaDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Lech ZarebaFaculty of Mathematics and Natural Sciences, University of Rzeszow, Rzeszow, Poland.
Romy KremersSynapse Research Institute, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Michal ZabczykCentre for Medical Research and Technologies, The John Paul II Hospital, Krakow, Poland.
Grazyna PulkaUniversity Hospital, Allergy and Clinical Immunology Department, Krakow, Poland.
Teresa IwaniecDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Jan G BazanInterdisciplinary Centre for Computational Modelling, University of Rzeszow, Rzeszow, Poland.
Coenraad HemkerSynapse Research Institute, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Anetta UndasDepartment of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland. mmundas@cyf-kr.edu.pl.
Jagiellonian University · PLJohn Paul II Hospital · PLRzeszów University · PLSynapse (Netherlands) · NLUniversity School of Physical Education in Kraków · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently we have reported that asthma is associated with enhanced plasma thrombin formation, impaired fibrinolysis and platelet activation. In the present study we investigated whether described prothrombotic blood alterations might predispose to thromboembolic events or asthma exacerbations. In 164 adult asthmatics we assessed clinical events during 3-year follow-up and analyzed their associations with measured at baseline prothrombotic blood parameters. Data were obtained from 157 (95.7%) of the asthma patients. We documented 198 severe asthma exacerbations (64/year), which occurred in 53 subjects (34%). These patients were older (p = 0.004), had worse asthma control (p = 0.02) and lower spirometry values (p = 0.01), at baseline. Interestingly, this subgroup had longer clot lysis time (CLT), as well as lower α

Indexed as

FibrinolysisAsthmaFemaleHumansMaleMiddle AgedPlasmaPregnancy-Associated alpha 2-MacroglobulinsRisk AssessmentPregnancy-Associated alpha 2-Macroglobulins

Identifiers

PMID28887505
PMCPMC5591306
OpenAlexW2750800737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.